Therapeutic Action
Anticholinergic antiparkinson drug
PDF page 59
Loading InternPractice…
Drug reference
Anticholinergic antiparkinson drug
PDF page 59
First-line treatment of extrapyramidal reactions induced by antipsychotics
PDF page 59
Do not administer to patients with closed-angle glaucoma, prostate disorders, gastrointestinal obstruction or atony. Administer with caution and carefully monitor use in elderly patients (risk of confusion, hallucinations). May cause: anticholinergic effects (dry mouth, constipation, blurred vision, tachycardia, disorders of micturition), confusion, hallucinations, memory impairment. Avoid or monitor combination with other drugs known to have anticholinergic effects (atropine, amitriptyline, chlorpromazine, promethazine, etc.). Pregnancy: re-evaluate whether the antipsychotic treatment is still necessary; if treatment is continued, administer biperiden at the lowest effective dose and observe the child if the mother rd was under treatment in the 3 trimester (risk of anticholinergic effect, e.g. tremors, abdominal distension). Breast-feeding: if treatment is necessary, administer at the lowest effective dose and observe the child (risk of anticholinergic effects, e.g. tachycardia, constipation, thickening of bronchial secretions).
PDF pages 59, 60
2 mg tablet
PDF page 59
Adult: 2 mg once daily, then increase if necessary up to 2 mg 2 to 3 times daily (max. 12 mg daily) Administer at the lowest effective dose in elderly patients and do not exceed 10 mg daily.
PDF page 59
As long as the antipsychotic treatment lasts.
PDF page 59
Also comes in 4 mg extended-release tablet, administered once daily. Biperiden is also used in the treatment of Parkinson’s disease.
PDF page 60
- - Below 25 °C
PDF page 60
2 mg once daily, then increase if necessary up to 2 mg 2 to 3 times daily (max. 12 mg daily)
PDF page 59